NAPSA


Summary: This gene encodes a member of the peptidase A1 family of aspartic proteases. The encoded preproprotein is proteolytically processed to generate an activation peptide and the mature protease. The activation peptides of aspartic proteinases function as inhibitors of the protease active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The encoded protease may play a role in the proteolytic processing of pulmonary surfactant protein B in the lung and may function in protein catabolism in the renal proximal tubules. This gene has been described as a marker for lung adenocarcinoma and renal cell carcinoma. [provided by RefSeq, Feb 2016].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

Gene Categories:

PROTEASEDRUGGABLE GENOME

GO terms in NAPSA


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF IDA GO:0004175 endopeptidase activity
MF IBA GO:0004190 aspartic-type endopeptidase activity
MF NAS GO:0004190 aspartic-type endopeptidase activity
MF IDA GO:0008233 peptidase activity
MF TAS GO:0008233 peptidase activity
CC IDA GO:0005615 extracellular space
Showing 1 to 6 of 15 rows rows per page

Gene expression in normal tissue: NAPSA

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Metabolic pathways1

Pathways in NAPSA


Loading, please wait...
Database
Pathway ID
Pathway Des.
kegg hsa04142 Lysosome - Homo sapiens (human)
reactome R-HSA-392499 Metabolism of proteins
reactome R-HSA-5683826 Surfactant metabolism
Showing 1 to 3 of 3 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD68 Paclitaxel 1
Showing 1 to 1 of 1 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in NAPSA

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​